C07C 233/66
Having the nitrogen atom of at least one of the carboxamide groups
Official title: having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
C07C233/66 (Having the nitrogen atom of at least one of the carboxamide groups) appears on 189 US grants and 228 published applications in this corpus.
Search patents in C07C- Granted patents
- 189
- Published applications
- 228
- Assignees
- 147
- Inventors
- 738
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 1 | 0 |
| 1998 | 7 | 0 |
| 1999 | 3 | 0 |
| 2000 | 5 | 0 |
| 2001 | 5 | 2 |
| 2002 | 3 | 8 |
| 2003 | 7 | 4 |
| 2004 | 2 | 10 |
| 2005 | 4 | 9 |
| 2006 | 4 | 6 |
| 2007 | 8 | 14 |
| 2008 | 3 | 9 |
| 2009 | 3 | 5 |
| 2010 | 8 | 12 |
| 2011 | 9 | 6 |
| 2012 | 7 | 8 |
| 2013 | 4 | 7 |
| 2014 | 14 | 19 |
| 2015 | 11 | 11 |
| 2016 | 12 | 22 |
| 2017 | 13 | 22 |
| 2018 | 8 | 6 |
| 2019 | 6 | 4 |
| 2020 | 2 | 11 |
| 2021 | 5 | 7 |
| 2022 | 5 | 5 |
| 2023 | 3 | 8 |
| 2024 | 4 | 7 |
| 2025 | 3 | 1 |
| 2026 | 4 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cyclopropylamide compounds against parasites in fish16 Jun 2026US 12,655,090 B2Intervet Inc.
- Antibacterial compounds2 Jun 2026US 12,643,875 B2The Penn State Research Foundation
- Inhibitors of the RAS oncoprotein, methods of making and methods of use thereof24 Mar 2026US 12,582,660 B2University of Louisville Research Foundation, Inc.
- 4-membered ring carboxamides used as nematicides6 Jan 2026US RE50,724 E1Syngenta Crop Protection AG
- Benzamide derivatives as cGAS-sting pathway agonists30 Dec 2025US 12,509,436 B2Baruch S. Blumberg Institute
- Antibacterial compounds17 Sep 2026US 2026/0274816 A1The Penn State Research Foundation
- Inhibitors of the ras oncoprotein, methods of making and methods of use thereof13 Aug 2026US 2026/0232689 A1University of Louisville Research Foundation, Inc.
- Synthesis methods and intermediates for the production of remimbrutinib23 Jul 2026US 2026/0209185 A1Novartis AG
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications2 Jul 2026US 2026/0184663 A1NucMito Pharmaceuticals Co. Ltd.
- Covalent, chemogenetic activators for k2p potassium channels and uses thereof9 Apr 2026US 2026/0098008 A1The Regents of the University of California
Most cited
By later US patents
- Inhibitors of human phosphatidyl-inositol 3-kinase delta138US 6,949,535 B2ICOS Corporation · 2005
- Inhibitors of human phosphatidylinositol 3-kinase delta135US 6,667,300 B2ICOS Corporation · 2003
- Anilide derivatives and their use for combating botrytis104US 5,330,995 ABASF SE · 1994
- Trisubstituted carbocyclic cyclophilin binding compounds and their use56US 6,656,971 B2Guilford Pharmaceuticals Inc. · 2003
- Diaminopropionic acid derivatives50US 6,331,640 B1Hoffmann-La Roche Inc. · 2001